| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 107,450 | 103,862 | 95,387 | | Cost of Revenue | 62,702 | 58,613 | 52,166 | | | Gross Profit | 44,748 | 45,249 | 43,221 | | | Operating Expenses | | Research Development | 8,678 | 7,320 | 5,380 | | Selling General and Administrative | 53,360 | 53,665 | 44,766 | | Non Recurring | (1,355) | 3,550 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (15,935) | (19,286) | (6,925) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,593 | 4,402 | 3,891 | | Earnings Before Interest And Taxes | (13,342) | (14,884) | (3,034) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (13,342) | (14,884) | (3,034) | | Income Tax Expense |
-
|
-
| 17,560 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,342) | (14,884) | (20,594) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (13,342) | (14,884) | (20,594) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,342) | ($14,884) | ($20,594) |
|
1.23% Nasdaq 
Income Statement
